Tatiana J Carneiro

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Magnetic Resonance

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela S C Bispo, Marlene Correia, Tatiana J Carneiro, Ana S Martins, Aliana A N Reis, Ana L M Batista de Carvalho, Maria Paula M Marques, Ana I Gil
Impact of Conventional and Potential New Metal-Based Drugs on Lipid Metabolism in Osteosarcoma MG-63 Cells. International journal of molecular sciences 24 (24) (2023)
Daniela S C Bispo, Marlene Correia, Tatiana J Carneiro, Ana S Martins, Aliana A N Reis, Ana L M Batista de Carvalho, Maria Paula M Marques, Ana I Gil
Impact of Conventional and Potential New Metal-Based Drugs on Lipid Metabolism in Osteosarcoma MG-63 Cells. International journal of molecular sciences 24 (24) (2023)
Tatiana J Carneiro, Martin Vojtek, Salomé Gonçalves-Monteiro, João R Neves, Ana L M Batista de Carvalho, Maria Paula M Marques, Carmen Diniz, Ana I Gil
Metabolic Impact of Anticancer Drugs Pd 2 Spermine and Cisplatin on the Brain of Healthy Mice. Pharmaceutics 14 (2) (2022)
Tatiana J Carneiro, Martin Vojtek, Salomé Gonçalves-Monteiro, Ana L M Batista de Carvalho, Maria Paula M Marques, Carmen Diniz, Ana I Gil
Effect of Pd 2 Spermine on Mice Brain-Liver Axis Metabolism Assessed by NMR Metabolomics. International journal of molecular sciences 23 (22) (2022)
Tatiana J Carneiro, Rita Araújo, Martin Vojtek, Salomé Gonçalves-Monteiro, Ana L M Batista de Carvalho, Maria Paula M Marques, Carmen Diniz, Ana I Gil
Impact of the Pd2Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model. International journal of molecular sciences 22 (19) (2021)
Tatiana J Carneiro, Rita Araújo, Martin Vojtek, Salomé Gonçalves-Monteiro, Carmen Diniz, Ana L M Batista de Carvalho, Maria Paula M Marques, Ana I Gil
Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent. Metabolites 11 (2) (2021)